-Down to Earth US actions jeopardise India's pro-poor patent laws that promote generic drugs production, says online global petition More than 75,000 people have requested Prime Minister Narendra Modi not to succumb to US pressure on Intellectual Property Rights (IP). With trade and intellectual property rights featuring prominently in the agenda of US president Barak Obama's India visit, civil society groups have expressed concern that talks on these issues are designed to make...
More »SEARCH RESULT
Who owns our genetic wealth? -Suman Sahai
-The Asian Age There was a news report not so long ago that ICRISAT (International Crops Research Institute for the Semi-Arid Tropics), an international organisation and part of the CGIAR (Consultative Group on International Agricultural Research) consortium, had entered into an agreement with Gubba Cold Storage Ltd. to set up a private seed bank, the first of its kind in India. No details were available of the terms and conditions under...
More »Making India Inc. accountable -Vidya Venkat
-The Hindu It is not the responsibility of the government alone to act in order to curb corruption; corporate firms need to be proactive as well in checking fraudulent financial practices The winter session of Parliament witnessed a noisy debate on the black money controversy. Governments of all hues have disappointed the Indian janata on the issue of black money and the failure is often associated with a perceived nexus between politicians...
More »MNCs deprive India of vital drugs -Rupali Mukherjee
-The Times of India MUMBAI: Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law. Corporates such as Japanese firm Otsuka Pharmaceuticals, US-based Bristol Myers-Squibb (BMS) and Swiss firm Novartis are deferring the launch of medicines critical for treatment of serious non-communicable diseases like cancer, HIV,...
More »Doesn't India Already Have an IPR Policy? -Sunil Mani
-Economic and Political Weekly The National Democratic Alliance government has constituted the IPR Think Tank which, among other things, is to draft the National Intellectual Property Rights Policy. India may not have a policy per se but it has a strong legislation on IPRs, a functioning patents office and mechanisms to grant patents as well as protect consumer interests. The Think Tank has other issues it needs to address, but is...
More »